WHO Sounds Warning Over Critical Scarcity of Weight-Loss Injections

Less than a tenth of patients who could benefit from GLP-1 drugs including Wegovy can access them, caution the WHO as it issues its inaugural advice on the therapies.

With in excess of 1,000,000,000 people worldwide now living with obesity, it is urging more widespread and fairer availability to GLP-1 medication.

According to estimates, in excess of 2,000,000,000 will be living with obesity by 2030 unless action is taken.

"Our new guidance affirms that excess weight is a long-term condition that can be treated with thorough and continuous care," remarked WHO director-general Tedros Adhanom Ghebreyesus.

Significant expense, limited production capacity, and logistical bottlenecks are key barriers to universal availability to the treatments that can assist patients in reducing substantial weight, notes the body.

Skinny Jab Shortage

Despite the present most optimistic scenario, the manufacturing of GLP-1 therapies could only cover approximately 100 million people – fewer than 10% of those who need them, as stated by the health organization.

The recommendation encourages nations and manufacturers to widen access, by measures like voluntary licensing.

Exclusive production rights on the active ingredient – the primary ingredient of Novo Nordisk's Wegovy – is set to lapse in several nations in 2026.

How Weight-Loss Jabs Function

These medications mimick a biological compound to slow digestion, suppress the appetite and enhance satiety so individuals consume fewer calories.

People typically see weight reduction in the initial weeks of beginning the regular doses.

Evidence points to users may see weight return a year later of halting the treatment, when their typical appetite come back.

To be above a healthy weight elevates your likelihood for contracting health problems, such as type 2 diabetes, cardiovascular issues, stroke, and certain malignancies.

Obesity concerns individuals in all nations and was associated with over three and a half million fatalities worldwide in 2024, as per the WHO.